Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
申请人:NPS Pharmaceuticals, Inc.
公开号:US06429207B1
公开(公告)日:2002-08-06
The present invention provides compounds, and pharmaceutical compositions containing those compounds, that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
本发明提供了在代谢型谷氨酸受体上具有活性的化合物和含有这些化合物的药物组合物,这些化合物对治疗神经系统疾病和障碍是有用的。同时还公开了制备这些化合物的方法。